Product
Toripalimab + Celecoxib
Aliases
Celecoxib, Toripalimab
Name
Toripalimab + Celecoxib
1 clinical trial
2 drugs
4 indications
Indication
Colorectal CancerIndication
Mismatch Repair-deficient (dMMR)Indication
Microsatellite Instability-high (MSI-H)Indication
Neoadjuvant TherapyDrug
CelecoxibClinical trial
Neoadjuvant PD-1 Blockade Toripalimab With or Without Celecoxib in Mismatch-repair Deficient or Microsatellite Instability-high Locally Advanced Colorectal Cancer (PICC): a Parallel-group, Randomized, Multi-cohort, Phase 2 TrialStatus: Recruiting, Estimated PCD: 2027-04-01